Alan L Rotman
Examiner (ID: 15220)
Most Active Art Unit | 1201 |
Art Unit(s) | 1802, 1612, 1201, 1203, 2899, 1625 |
Total Applications | 2275 |
Issued Applications | 1794 |
Pending Applications | 68 |
Abandoned Applications | 413 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16960843
[patent_doc_number] => 20210212342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING
[patent_app_type] => utility
[patent_app_number] => 17/130195
[patent_app_country] => US
[patent_app_date] => 2020-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/130195 | USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING | Dec 21, 2020 | Pending |
Array
(
[id] => 18518578
[patent_doc_number] => 11708461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Method for preparing acylated crosslinked glycosaminoglycans
[patent_app_type] => utility
[patent_app_number] => 17/129366
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13064
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129366 | Method for preparing acylated crosslinked glycosaminoglycans | Dec 20, 2020 | Issued |
Array
(
[id] => 16776523
[patent_doc_number] => 20210113600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/127107
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127107 | RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS | Dec 17, 2020 | Pending |
Array
(
[id] => 18701293
[patent_doc_number] => 11787792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/124606
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16454
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124606 | 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof | Dec 16, 2020 | Issued |
Array
(
[id] => 19105835
[patent_doc_number] => 11958916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Use of poly alpha-1,3-glucan ethers as viscosity modifiers
[patent_app_type] => utility
[patent_app_number] => 17/118754
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35969
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118754 | Use of poly alpha-1,3-glucan ethers as viscosity modifiers | Dec 10, 2020 | Issued |
Array
(
[id] => 18492256
[patent_doc_number] => 11697667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Salts and polymorphs of cethromycin for the treatment of disease
[patent_app_type] => utility
[patent_app_number] => 17/109970
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23475
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109970 | Salts and polymorphs of cethromycin for the treatment of disease | Dec 1, 2020 | Issued |
Array
(
[id] => 16868463
[patent_doc_number] => 20210161930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS
[patent_app_type] => utility
[patent_app_number] => 17/104414
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104414 | Use of SGLT-2 inhibitors in the drying-off of non-human mammals | Nov 24, 2020 | Issued |
Array
(
[id] => 16688412
[patent_doc_number] => 20210070888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => MODIFIED BIOPOLYMERS AND METHODS OF PRODUCING AND USING THE SAM
[patent_app_type] => utility
[patent_app_number] => 17/100523
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100523 | MODIFIED BIOPOLYMERS AND METHODS OF PRODUCING AND USING THE SAM | Nov 19, 2020 | Abandoned |
Array
(
[id] => 16686750
[patent_doc_number] => 20210069225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => LIPONUCLEOTIDE-BASED THERAPY FOR ARDS
[patent_app_type] => utility
[patent_app_number] => 16/952557
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952557 | LIPONUCLEOTIDE-BASED THERAPY FOR ARDS | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18460352
[patent_doc_number] => 11684630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Synthetic composition and method for modulating brain function and behaviour
[patent_app_type] => utility
[patent_app_number] => 17/099306
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5685
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099306 | Synthetic composition and method for modulating brain function and behaviour | Nov 15, 2020 | Issued |
Array
(
[id] => 18117751
[patent_doc_number] => 11549133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Preparation method of amylodextrin
[patent_app_type] => utility
[patent_app_number] => 17/094962
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3331
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094962 | Preparation method of amylodextrin | Nov 10, 2020 | Issued |
Array
(
[id] => 16686747
[patent_doc_number] => 20210069222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/094591
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17094591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/094591 | TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS | Nov 9, 2020 | Pending |
Array
(
[id] => 16990162
[patent_doc_number] => 20210228582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMBINATION THERAPIES FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/061821
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061821 | COMBINATION THERAPIES FOR TREATMENT OF CANCER | Oct 1, 2020 | Abandoned |
Array
(
[id] => 16596571
[patent_doc_number] => 20210023102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOSITIONS FOR USE IN IMPROVING STOOL CONSISTENCY OR FREQUENCY IN INFANTS OR YOUNG CHILDREN
[patent_app_type] => utility
[patent_app_number] => 17/034650
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/034650 | COMPOSITIONS FOR USE IN IMPROVING STOOL CONSISTENCY OR FREQUENCY IN INFANTS OR YOUNG CHILDREN | Sep 27, 2020 | Pending |
Array
(
[id] => 16718623
[patent_doc_number] => 20210085770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
[patent_app_type] => utility
[patent_app_number] => 17/025947
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17025947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/025947 | Neoglycoconjugates as vaccines and therapeutic tools | Sep 17, 2020 | Issued |
Array
(
[id] => 16726580
[patent_doc_number] => 20210093727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/021909
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021909 | Sulfoalkyl ether cyclodextrin compositions | Sep 14, 2020 | Issued |
Array
(
[id] => 16671405
[patent_doc_number] => 20210060168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/011880
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011880 | ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES | Sep 2, 2020 | Pending |
Array
(
[id] => 19290410
[patent_doc_number] => 12029749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
[patent_app_type] => utility
[patent_app_number] => 17/010648
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26169
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010648 | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine | Sep 1, 2020 | Issued |
Array
(
[id] => 18051605
[patent_doc_number] => 11524976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Oligonucleotide synthesizer
[patent_app_type] => utility
[patent_app_number] => 17/005854
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7274
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005854 | Oligonucleotide synthesizer | Aug 27, 2020 | Issued |
Array
(
[id] => 16898105
[patent_doc_number] => 20210177021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => METHOD OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/999483
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999483 | METHOD OF PRODUCTION | Aug 20, 2020 | Pending |